Might Big Pharma retaliate by raising Canadian drug prices to be more in line with American prices?
No. Again, because of the Patented Medicine Prices Review Board (PMPRB) process, any price increases that would be acceptable under the agreement would be tied to the rate of inflation. Any suggestion that there are exceptions to this rule are baseless. This fact was affirmed by Dr. Robert Elgie, the Chairperson of the PMPRB, in his recent speech on the future of pharmaceutical price controls in Canada.
